{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:11:34Z","timestamp":1790428294750,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["13142271"],"award-info":[{"award-number":["13142271"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.phrs.2020.105157","type":"journal-article","created":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T17:35:49Z","timestamp":1597599349000},"page":"105157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis"],"prefix":"10.1016","volume":"161","author":[{"given":"David W","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingo MH","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yau-Sang","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Biao","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen KL","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzi-Bun","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hextan YS","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.phrs.2020.105157_bib0005","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1158\/1055-9965.EPI-17-0290","article-title":"Recent Trends in Ovarian Cancer Incidence and Relative Survival in the United States by Race\/Ethnicity and Histologic Subtypes","volume":"26","author":"Park","year":"2017","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"2","key":"10.1016\/j.phrs.2020.105157_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1369\/0022155417742897","article-title":"Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review","volume":"66","author":"van Baal","year":"2018","journal-title":"J Histochem Cytochem."},{"issue":"suppl_8","key":"10.1016\/j.phrs.2020.105157_bib0015","doi-asserted-by":"crossref","first-page":"viii13","DOI":"10.1093\/annonc\/mdx446","article-title":"Acquired chemotherapy resistance in ovarian cancer","volume":"28","author":"Christie","year":"2017","journal-title":"Ann Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105157_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","article-title":"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism","volume":"1","author":"Kahn","year":"2005","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.phrs.2020.105157_bib0025","doi-asserted-by":"crossref","first-page":"e53597","DOI":"10.1371\/journal.pone.0053597","article-title":"AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt\/beta-catenin signaling activity","volume":"8","author":"Kwan","year":"2013","journal-title":"PLoS One."},{"issue":"13","key":"10.1016\/j.phrs.2020.105157_bib0030","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.7150\/jca.19873","article-title":"Metformin Sensitizes Leukemia Cells to Vincristine via Activation of AMP-activated Protein Kinase","volume":"8","author":"Yi","year":"2017","journal-title":"Journal of Cancer."},{"issue":"Pt A","key":"10.1016\/j.phrs.2020.105157_bib0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.phrs.2016.10.006","article-title":"Metformin: An anti-diabetic drug to fight cancer","volume":"113","author":"Daugan","year":"2016","journal-title":"Pharmacological research"},{"issue":"5","key":"10.1016\/j.phrs.2020.105157_bib0040","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1142\/S0192415X18500507","article-title":"Application of Traditional Chinese Medicines as Personalized Therapy in Human Cancers","volume":"46","author":"Wang","year":"2018","journal-title":"The American journal of Chinese medicine"},{"issue":"5","key":"10.1016\/j.phrs.2020.105157_bib0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/1386207320666170116141818","article-title":"Anticancer Properties of Traditional Chinese Medicine","volume":"20","author":"Yan","year":"2017","journal-title":"Combinatorial chemistry & high throughput screening"},{"issue":"5","key":"10.1016\/j.phrs.2020.105157_bib0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/156652411795976583","article-title":"Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties","volume":"11","author":"Fang","year":"2011","journal-title":"Current molecular medicine."},{"issue":"3","key":"10.1016\/j.phrs.2020.105157_bib0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1534735415611747","article-title":"Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade","volume":"15","author":"Yung","year":"2016","journal-title":"Integr Cancer Ther."},{"issue":"2","key":"10.1016\/j.phrs.2020.105157_bib0060","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/bbrc.1995.1405","article-title":"Potentiation of anti-HIV activity of anti-inflammatory drugs, dexamethasone and indomethacin, by MAP30, the antiviral agent from bitter melon","volume":"208","author":"Bourinbaiar","year":"1995","journal-title":"Biochemical and biophysical research communications."},{"issue":"4","key":"10.1016\/j.phrs.2020.105157_bib0065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/2211-5463.12577","article-title":"NSC-34 motor neuron-like cells are sensitized to ferroptosis upon differentiation","volume":"9","author":"Martinez","year":"2019","journal-title":"FEBS Open Bio."},{"issue":"18","key":"10.1016\/j.phrs.2020.105157_bib0070","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","article-title":"Combenefit: an interactive platform for the analysis and visualization of drug combinations","volume":"32","author":"Di Veroli","year":"2016","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.phrs.2020.105157_bib0075","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1158\/1535-7163.MCT-10-0777","article-title":"AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia","volume":"10","author":"Kuznetsov","year":"2011","journal-title":"Mol Cancer Ther."},{"issue":"1","key":"10.1016\/j.phrs.2020.105157_bib0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1471-2407-13-327","article-title":"Activation of AMPK inhibits cervical cancer cell growth through AKT\/FOXO3a\/FOXM1 signaling cascade","volume":"13","author":"Yung","year":"2013","journal-title":"BMC cancer."},{"key":"10.1016\/j.phrs.2020.105157_bib0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ceca.2017.05.007","article-title":"The role of Ca(2+) in cell death caused by oxidative glutamate toxicity and ferroptosis","volume":"70","author":"Maher","year":"2018","journal-title":"Cell Calcium."},{"key":"10.1016\/j.phrs.2020.105157_bib0090","doi-asserted-by":"crossref","first-page":"5080843","DOI":"10.1155\/2019\/5080843","article-title":"Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis","volume":"2019","author":"Su","year":"2019","journal-title":"Oxid Med Cell Longev."},{"issue":"5","key":"10.1016\/j.phrs.2020.105157_bib0095","article-title":"Glutathione: Antioxidant Properties Dedicated to Nanotechnologies","volume":"7","author":"Gaucher","year":"2018","journal-title":"Antioxidants (Basel)."},{"issue":"12","key":"10.1016\/j.phrs.2020.105157_bib0100","doi-asserted-by":"crossref","first-page":"e0225931","DOI":"10.1371\/journal.pone.0225931","article-title":"a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo","volume":"14","author":"Shibata","year":"2019","journal-title":"PLoS One."},{"issue":"12","key":"10.1016\/j.phrs.2020.105157_bib0105","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.neo.2017.10.005","article-title":"Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells","volume":"19","author":"Hao","year":"2017","journal-title":"Neoplasia."},{"issue":"12","key":"10.1016\/j.phrs.2020.105157_bib0110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/omi.2018.0172","article-title":"Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling","volume":"22","author":"Dzobo","year":"2018","journal-title":"OMICS."},{"issue":"1","key":"10.1016\/j.phrs.2020.105157_bib0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","article-title":"AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo","volume":"17","author":"Faubert","year":"2013","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.phrs.2020.105157_bib0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/path.4298","article-title":"Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again?","volume":"232","author":"Drake","year":"2014","journal-title":"J Pathol."},{"issue":"11","key":"10.1016\/j.phrs.2020.105157_bib0125","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nature medicine."},{"issue":"12","key":"10.1016\/j.phrs.2020.105157_bib0130","doi-asserted-by":"crossref","first-page":"e81859","DOI":"10.1371\/journal.pone.0081859","article-title":"Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance","volume":"8","author":"Nowicka","year":"2013","journal-title":"PLoS One."},{"issue":"3","key":"10.1016\/j.phrs.2020.105157_bib0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1142\/S0192415X09006941","article-title":"New exploration and understanding of traditional Chinese medicine","volume":"37","author":"Xutian","year":"2009","journal-title":"The American journal of Chinese medicine"},{"issue":"3","key":"10.1016\/j.phrs.2020.105157_bib0140","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1142\/S0192415X14500359","article-title":"Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development","volume":"42","author":"Wang","year":"2014","journal-title":"The American journal of Chinese medicine"},{"key":"10.1016\/j.phrs.2020.105157_bib0145","doi-asserted-by":"crossref","first-page":"496169","DOI":"10.1155\/2015\/496169","article-title":"Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome","volume":"2015","author":"Alam","year":"2015","journal-title":"J Lipids."},{"issue":"2","key":"10.1016\/j.phrs.2020.105157_bib0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/187153008784534330","article-title":"Traditional chinese medicine in treatment of metabolic syndrome","volume":"8","author":"Yin","year":"2008","journal-title":"Endocr Metab Immune Disord Drug Targets."},{"issue":"4","key":"10.1016\/j.phrs.2020.105157_bib0155","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11418-017-1099-0","article-title":"Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells","volume":"71","author":"Pitchakarn","year":"2017","journal-title":"Journal of natural medicines"},{"key":"10.1016\/j.phrs.2020.105157_bib0160","doi-asserted-by":"crossref","first-page":"33532","DOI":"10.1038\/srep33532","article-title":"BG-4, a novel anticancer peptide from bitter gourd (Momordica charantia), promotes apoptosis in human colon cancer cells","volume":"6","author":"Dia","year":"2016","journal-title":"Scientific reports."},{"issue":"4","key":"10.1016\/j.phrs.2020.105157_bib0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10495-011-0684-z","article-title":"RNase MC2: a new Momordica charantia ribonuclease that induces apoptosis in breast cancer cells associated with activation of MAPKs and induction of caspase pathways","volume":"17","author":"Fang","year":"2012","journal-title":"Apoptosis: an international journal on programmed cell death"},{"issue":"4","key":"10.1016\/j.phrs.2020.105157_bib0170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ajhp\/60.4.356","article-title":"Bitter melon (Momordica charantia): a review of efficacy and safety","volume":"60","author":"Basch","year":"2003","journal-title":"American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists."},{"issue":"8","key":"10.1016\/j.phrs.2020.105157_bib0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11306-019-1565-7","article-title":"Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine","volume":"15","author":"Zhou","year":"2019","journal-title":"Metabolomics."},{"issue":"1","key":"10.1016\/j.phrs.2020.105157_bib0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2012.05.005","article-title":"The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo","volume":"324","author":"Fang","year":"2012","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.phrs.2020.105157_bib0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/abbs\/gmv128","article-title":"Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges","volume":"48","author":"Yung","year":"2016","journal-title":"Acta Biochim Biophys Sin (Shanghai)."},{"key":"10.1016\/j.phrs.2020.105157_bib0190","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.12688\/f1000research.11960.1","article-title":"AMP-activated protein kinase - not just an energy sensor","volume":"6","author":"Hardie","year":"2017","journal-title":"F1000Research."},{"key":"10.1016\/j.phrs.2020.105157_bib0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1476-4598-13-49","article-title":"Reduced expression of AMPK-beta1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer","volume":"13","author":"Li","year":"2014","journal-title":"Mol Cancer."},{"issue":"11","key":"10.1016\/j.phrs.2020.105157_bib0200","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.trecan.2016.10.006","article-title":"mTOR Signaling Confers Resistance to Targeted Cancer Drugs","volume":"2","author":"Guri","year":"2016","journal-title":"Trends in cancer."},{"issue":"2","key":"10.1016\/j.phrs.2020.105157_bib0205","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signalling pathway in human cancer","volume":"13","author":"Populo","year":"2012","journal-title":"International journal of molecular sciences"},{"key":"10.1016\/j.phrs.2020.105157_bib0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s42003-019-0508-1","article-title":"Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells","volume":"2","author":"Chen","year":"2019","journal-title":"Commun Biol."},{"key":"10.1016\/j.phrs.2020.105157_bib0215","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","article-title":"Calcium and ROS: A mutual interplay","volume":"6","author":"Gorlach","year":"2015","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105157_bib0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ceca.2016.03.005","article-title":"Calcium and reactive oxygen species in regulation of the mitochondrial permeability transition and of programmed cell death in yeast","volume":"60","author":"Carraro","year":"2016","journal-title":"Cell Calcium."},{"issue":"4","key":"10.1016\/j.phrs.2020.105157_bib0225","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tips.2020.01.010","article-title":"Polyunsaturated Fatty Acid Deuteration against Neurodegeneration","volume":"41","author":"Shchepinov","year":"2020","journal-title":"Trends Pharmacol Sci."},{"issue":"1-2","key":"10.1016\/j.phrs.2020.105157_bib0230","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell."},{"issue":"15","key":"10.1016\/j.phrs.2020.105157_bib0235","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","article-title":"AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System Xc(-) Activity","volume":"28","author":"Song","year":"2018","journal-title":"Curr Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105157_bib0240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","article-title":"Energy-stress-mediated AMPK activation inhibits ferroptosis","volume":"22","author":"Lee","year":"2020","journal-title":"Nat Cell Biol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820314651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820314651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:26:37Z","timestamp":1760912797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820314651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":48,"alternative-id":["S1043661820314651"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105157","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105157"}}